Chemo-Free Regimen May Be Frontline Option for HR+, HER2+ Metastatic Breast Cancer

Anastrozole plus palbociclib, trastuzumab, and pertuzumab may provide a chemotherapy-free frontline treatment option for HR+, HER2+ metastatic breast cancer. Anastrozole plus palbociclib, trastuzumab, and pertuzumab may provide a chemotherapy-free frontline treatment option for HR+, HER2+ metastatic breast cancer.

Related Keywords

New York ,United States ,San Antonio ,Texas ,Amy Tiersten , ,San Antonio Breast Cancer Symposium ,Mount Sinai ,